First Evidence: TRAP-Induced Platelet Aggregation Is Reduced in Patients Receiving Xabans

The availability of direct oral anticoagulants has caused a paradigm shift in the management of thrombosis. Rivaroxaban and apixaban are 2 direct oral anticoagulants whose target specificity is activated factor X (FXa). However, it is still not fully understood if and how xabans impact platelet func...

Descripción completa

Detalles Bibliográficos
Autores principales: Nehaj, Frantisek, Sokol, Juraj, Ivankova, Jela, Mokan, Michal, Kovar, Frantisek, Stasko, Jan, Mokan, Marian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2017
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6714725/
https://www.ncbi.nlm.nih.gov/pubmed/29050502
http://dx.doi.org/10.1177/1076029617734310

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6714725/
https://www.ncbi.nlm.nih.gov/pubmed/29050502
http://dx.doi.org/10.1177/1076029617734310

Ejemplares similares